Compare Tanah Laut Tbk (INDX) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tanah Laut Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Tanah Laut Tbk trades at Rp60 (market cap 26.27B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 6.3× Tanah Laut Tbk's market cap. Which is the better fit depends on your goals.
| INDX | OBAT | |
|---|---|---|
Market Cap | 26.27B | 166.01B |
Volume | — | 324K |
Lot | — | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tanah Laut Tbk
PT Tanah Laut Tbk formerly PT Indoexchange Tbk (the Company) was established under the name PT Sanggrahamas Dipta based on Notarial Deed No.78 dated September 19, 1991 of Rahmah Arie Sutarjo, S.H., notary in Jakarta. The Company changed its status from Foreign Capital Investment Company to Domestic Capital Investment Company, approved by the Chairman of Capital Investment Coordinating Board in accordance with Approval Letter No. 38/V/PMDN/2008 dated September 23, 2008.
Read more on INDX →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
